More Press Releases

View Older Stories View Newer Stories

Sep 22, 2025 01:39AM Climate Change in the Classroom Announced by Robert W. Collin
Sep 21, 2025 08:01PM Buzz Rocket Launches Crypto Content Marketing Service For Traffic Improvement
Sep 22, 2025 01:30AM Medincell: New Data Show that UZEDY® Initiation in Hospitalized Patients is Associated with Faster Discharge and an Overall Clinician Preference Compared to Invega Sustenna®
Sep 22, 2025 01:30AM Medincell: New Pivotal Phase 3 Long-Term Data Supports Olanzapine Long-Acting Injectable (LAI) with Favorable Safety Profile – No PDSS Observed
Sep 22, 2025 01:30AM ASMED Surgical Center Marks 20,000th FUE Procedure Amid Global Hair Restoration Growth
Sep 22, 2025 01:29AM Imagen Network (IMAGE) Prepares Ethereum Reserve Acquisition to Reinforce Ecosystem Growth
Sep 22, 2025 01:30AM Sampo plc’s share buybacks 19 September 2025
Sep 22, 2025 01:30AM CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
Sep 22, 2025 01:23AM ASMED Surgical Center Marks 20,000th FUE Procedure AmidGlobal Hair Restoration Growth
Sep 22, 2025 01:12AM Chery Super Hybrid (CSH) Concludes European Seven-Country Endurance Test in the Czech Republic, Ushering in a New Era of Globalization
Sep 22, 2025 01:12AM Chery Super Hybrid (CSH) Concludes European Seven-Country Endurance Test in the Czech Republic, Ushering in a New Era of Globalization
Sep 22, 2025 01:12AM Chery Super Hybrid (CSH) Concludes European Seven-Country Endurance Test in the Czech Republic, Ushering in a New Era of Globalization
Sep 22, 2025 01:12AM Chery Super Hybrid (CSH) Concludes European Seven-Country Endurance Test in the Czech Republic, Ushering in a New Era of Globalization
Sep 22, 2025 01:05AM Positive Phase III Results Show Genentech’s Giredestrant Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer
Sep 22, 2025 01:00AM Aelis Farma Reports 2025 Half-Year Financial Results and Presents Progress and Development Outlook
Sep 22, 2025 01:00AM Razor Labs Announces Strategic Partnership with Process Automation to Accelerate AI-Driven Digital Transformation in South African Mining
Sep 22, 2025 01:00AM Climate-resilient food innovation: International consortium aims to produce food prototypes derived from CO2
Sep 22, 2025 01:00AM IP Excellera expands in the United Arab Emirates with new office in Abu Dhabi, headed by Partner Nour Sukkar
Sep 22, 2025 01:00AM International Petroleum Corporation to Arrange Fixed Income Investor Meetings
Sep 22, 2025 01:00AM CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models
Sep 22, 2025 01:00AM Start of Day Message
Sep 22, 2025 01:00AM Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
Sep 22, 2025 01:00AM Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
Sep 22, 2025 01:00AM Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III
Sep 22, 2025 01:00AM Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer
Sep 22, 2025 01:00AM Prosafe SE: Operational update – August 2025
Sep 22, 2025 01:00AM Corbion reports the progress of its share buyback program 15 September – 19 September 2025
Sep 22, 2025 12:30AM VT Markets launches brand film to showcase shared values with NUFC to mark the beginning of the partnership's second year
Sep 22, 2025 12:30AM Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sep 22, 2025 12:29AM Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
Sep 22, 2025 12:21AM Anhui: Where Innovation Meets Cultural Heritage
Sep 22, 2025 12:15AM Silver One Commences Ground Geophysical Survey at Its Phoenix Silver Project and Advances Candelaria PEA
Sep 22, 2025 12:15AM First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs
Sep 22, 2025 12:01AM Agentic AI, Digital Currencies and Real-Time Transactions Reshape Global Payments Landscape
Sep 22, 2025 12:00AM Hyperproof Launches Hyperproof AI: The First End-to-End AI GRC Engine That Accelerates Business Growth
Sep 21, 2025 11:45PM CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders
Sep 21, 2025 11:25PM SEMI Issues Statement on U.S. H1-B Visa Policy Announcement
Sep 21, 2025 11:14PM ICEX and SOSA Launch Desafía San Francisco to Accelerate Spanish Startups in Silicon Valley
Sep 21, 2025 10:55PM Quantum Computing Inc. Announces $500 Million Oversubscribed Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
Sep 21, 2025 10:00PM Yokogawa Signs Agreements with Toyota for the R&D of the Control Platform for a Manned Pressurized Rover
Sep 21, 2025 10:00PM Update on Nasdaq Ex-Dividend Date
Sep 21, 2025 09:48PM Sheet Sherpa Released as Free Solution for Professionals Managing Large Excel Files
Sep 21, 2025 09:26PM Xinhua Silk Road: Dehua International Porcelain Culture Week opened to showcase charm of China's white porcelain to world
Sep 21, 2025 09:00PM Century Pacific Selects Blue Yonder’s AI-Powered Solution To Digitally Transform Its Demand and Supply Planning
Sep 21, 2025 09:00PM FICO Survey: Only 1 in 10 APAC Bank Leaders Say Their Bank Is Highly Advanced in Hyper-Personalization
Sep 21, 2025 08:48PM Bybit Becomes the First Exchange to List ASTER, Launches Exclusive Campaigns With Rewards up to 100,000 USDT
Sep 21, 2025 08:30PM Eye Level Math Olympiad 2025 Opens Registration for Students Worldwide
Sep 21, 2025 08:29PM AusperBio Raises $63 Million in Series B2 Financing to Accelerate Functional Cure Therapies for Chronic Hepatitis B
Sep 21, 2025 08:10PM Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
Sep 21, 2025 08:00PM WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
View Newer Stories View Older Stories